ProQR Therapeutics Eulerpool News

ProQR Therapeutics Eulerpool-AFX

ProQR Therapeutics Stock News

ProQR Therapeutics is being monitored by journalists and investors worldwide. We gather the latest ProQR Therapeutics news here.

• May 22 ·

  TipRanks
  ProQR Shareholders Approve Key Resolutions
• May 13 ·

  Yahoo
  Shareholders in ProQR Therapeutics (NASDAQ:PRQR) are in the red if they invested five years ago
• May 11 ·

  SeekingAlpha
  ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript)
• May 10 ·

  TipRanks
  Buy Rating Affirmed for ProQR on Promising RNA Editing Technology and Solid Financial Footing
• May 10 ·

  TipRanks
  ProQR’s Axiomer Platform Technology Shows Promise: Analyst Maintains Buy Rating on Robust Editing Efficacy and Clinical Development Potential
• May 9 ·

  Yahoo
  ProQR Announces First Quarter 2024 Operating and Financial Results
• May 9 ·

  TipRanks
  ProQR Therapeutics Reports Quarterly Financials
• May 9 ·

  Seeking Alpha
  ProQR GAAP EPS of -€0.09, revenue of €4.45M
• May 9 ·

  Thefly.com
  ProQR Therapeutics reports Q1 EPS (EUR 0.09) vs. (EUR 0.11) last year
• May 8 ·

  Yahoo
  ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases